Integrin-driven monocyte to dendritic cell conversion in modified extracorporeal photochemotherapy

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Extracorporeal photochemotherapy (ECP) is a standard treatment for cutaneous T cell lymphoma (CTCL) and graft-versus-host disease (GVHD).
• The precise cellular mechanisms underlying ECP's efficacy, particularly its role in dendritic cell (DC) modulation, remain incompletely understood.
• ECP's ability to induce antigen-presenting cell (DC)-mediated immune responses suggests involvement of cell signaling pathways.

Purpose of the Study:

• To investigate the role of integrin signaling and adsorbed plasma proteins in monocyte-to-DC differentiation during ECP.
• To elucidate the specific molecular mechanisms by which ECP influences immune cell differentiation.

Main Methods:

• Utilized two model systems of ECP to analyze monocyte-to-DC differentiation.
• Examined the adhesion of monocytes to plasma proteins (fibronectin) adsorbed onto ECP plates.
• Assessed DC differentiation markers (CD80, CD86, CD36, HLA-DR, CD83) and integrin signaling pathways (RGD motif, αVβ3, α5β1).

Main Results:

• Monocytes adhered to adsorbed plasma proteins on ECP plates, initiating signaling pathways for differentiation.
• Plasma protein adsorption significantly enhanced monocyte-to-DC differentiation (54.2% ± 4.7%), with fibronectin alone supporting 29.8% ± 7.2%.
• The arginine-glycine-aspartic (RGD) motif in plasma proteins drove differentiation via αVβ3 and α5β1 integrin signaling, with high-density RGD substrates yielding 54.1% ± 5.8% differentiation.

Conclusions:

• Plasma protein binding via integrins is a key mechanism driving monocyte-to-DC differentiation in ECP.
• Specific binding domains of plasma proteins and integrins are crucial for this process.
• Understanding this mechanism offers potential strategies to enhance the therapeutic efficacy of ECP.